ARTICLE | Company News
Curis, Norak deal
October 25, 2004 7:00 AM UTC
Norak will use its Transfluor G protein-coupled receptor (GPCR) technology to develop cell lines expressing selected receptors from CRIS. Financial terms were not disclosed. Norak licensed the Transfl...